PD-L1 expression associates with favorable survival of patients with cancer of unknown primary (CUP) not treated with checkpoint inhibitors

Abu Sabbah, Tanja; Theurer, Sarah; Baba, Hideo Andreas; Lueong, Smiths; Rashidi-Alavijeh, Jassin; Hilser, Thomas; Zaun, Yasmin; Metzenmacher, Martin; Pogorzelski, Michael; Virchow, Isabel; Pretzell, Ina; Kostbade, Karina; Treckmann, Jürgen; Wiesweg, Marcel; Schuler, Martin; Kasper, Stefan; Zaun, Gregor

doi:10.1016/j.ejca.2024.114268

European Journal of Cancer

2024

DOI: 10.1016/j.ejca.2024.114268

|View full text |Cite

PD-L1 expression associates with favorable survival of patients with cancer of unknown primary (CUP) not treated with checkpoint inhibitors

Tanja Abu Sabbah,

Sarah Theurer,

Hideo Andreas Baba

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Letter Re: PD-L1 expression associates with favorable survival of patients with cancer of unknown primary (CUP) not treated with checkpoint inhibitors

Yu,

Xiao

2024

European Journal of Cancer

View full text Add to dashboard Cite

Letter Re: PD-L1 expression associates with favorable survival of patients with cancer of unknown primary (CUP) not treated with checkpoint inhibitors

Yu,

Xiao

2024

European Journal of Cancer

View full text Add to dashboard Cite

Letter of response re: PD-L1 expression associates with favorable survival of patients with cancer of unknown primary (CUP) not treated with checkpoint inhibitors

Zaun

2024

European Journal of Cancer

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

PD-L1 expression associates with favorable survival of patients with cancer of unknown primary (CUP) not treated with checkpoint inhibitors

Cited by 2 publications

References 14 publications

Letter Re: PD-L1 expression associates with favorable survival of patients with cancer of unknown primary (CUP) not treated with checkpoint inhibitors

Letter Re: PD-L1 expression associates with favorable survival of patients with cancer of unknown primary (CUP) not treated with checkpoint inhibitors

Letter of response re: PD-L1 expression associates with favorable survival of patients with cancer of unknown primary (CUP) not treated with checkpoint inhibitors

Contact Info

Product

Resources

About